NEW YORK (GenomeWeb) – GenMark Diagnostics said Thursday that it has achieved CE marking under the European In‐Vitro Diagnostic Devices Directive for its ePlex Blood Culture Identification fungal pathogen panel.

The panel is the first in the GenMark Sepsis Solution, which will also include BCID Gram-Positive and Gram-Negative panels, the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.